CPR Pharma Services Pty Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CPR Pharma Services Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10574
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CPR Pharma Services Pty Ltd (CPR) is a contract research organization that offers drug development and clinical trial services. The organization’s services include clinical project management and monitoring, data management, statistical and pharmacokinetic services, and bioanalytical services. Its clinical project management services comprise feasibility assessments, study design, protocol development and review, ethics committee submissions, review of eCRF design and development, investigator selection, site selection, pre-study visits, initiation visits, monitoring, close-out visits, CSR writing, and others. CPR offers services in the therapeutic areas of AIDS or HIV, acute pain, antibiotics, cardiovascular, chronic pain, dermatology, gastrointestinal, gynecology and fertility, hematology, infectious diseases, neurology, oncology, ophthalmology, periodontology, respiratory, among others. It caters to biotechnology and pharmaceutical companies. CPR is headquartered in Thebarton, South Australia, Australia.

CPR Pharma Services Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Proteomics International Labs to Enter into Partnership with CPR Pharma Services 10
Acquisition 11
Proteomics International to Sell Stake in CPR Pharma Services 11
Proteomics International Labs to Acquire 10% Stake in CPR Pharma Services 12
CPR Pharma Services Pty Ltd – Key Competitors 13
CPR Pharma Services Pty Ltd – Key Employees 14
CPR Pharma Services Pty Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CPR Pharma Services Pty Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Proteomics International Labs to Enter into Partnership with CPR Pharma Services 10
Proteomics International to Sell Stake in CPR Pharma Services 11
Proteomics International Labs to Acquire 10% Stake in CPR Pharma Services 12
CPR Pharma Services Pty Ltd, Key Competitors 13
CPR Pharma Services Pty Ltd, Key Employees 14

List of Figures
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CPR Pharma Services Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CPR Pharma Services Pty Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sun A. Kaken Co. Ltd.:企業の戦略・SWOT・財務情報
    Sun A. Kaken Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun A. Kaken Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Telormedix SA-製薬・医療分野:企業M&A・提携分析
    Summary Telormedix SA (Telormedix) is a biopharmaceutical company. The company develops and provides immune drugs for the treatment of cancer and other infectious diseases. It offers products such as TMX-201, TMX-202 and vesimune (TMX-101). Its vesimune (TMX-101) provides treatment for superficial b …
  • ET Solar Group Corporation:電力:M&Aディール及び事業提携情報
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and inves …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ferrellgas Partners, L.P.:企業の戦略・SWOT・財務情報
    Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Arcbest Corp.
    Arcbest Corp. - Strategy, SWOT and Corporate Finance Report Summary Arcbest Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zhejiang Jolly Pharmaceutical Co Ltd (300181):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Jolly Pharmaceutical Co Ltd (Zhejiang Jolly Pharma) is a producer and marketer of pharmaceutical products. The company offers products in the form of tablets, capsules, granules, injections, dry powders, and others. Its products include Wuling powder, pseudomonas moth powder, cordyc …
  • ADT LLC:戦略・SWOT・企業財務分析
    ADT LLC - Strategy, SWOT and Corporate Finance Report Summary ADT LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • PDL BioPharma Inc (PDLI):医療機器:M&Aディール及び事業提携情報
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Healthscope Ltd (HSO):製薬・医療:M&Aディール及び事業提携情報
    Summary Healthscope Ltd (Healthscope) is an integrated healthcare provider that provides healthcare services through the ownership and management of hospitals and pathology laboratories. The company operates through private hospitals in Australia and pathology laboratories in New Zealand. It provide …
  • Haworth Inc:企業の戦略的SWOT分析
    Haworth Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • China Digital Culture (Group) Ltd (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Ltd (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Trellis Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Trellis Bioscience Inc (Trellis) is a healthcare services provider that offers therapies. The company discovers and develops human antibody therapeutics for the treatment of infectious diseases and cancer indications. It provides technology to defeat the deficiencies of current screening met …
  • SenGenix Inc:医療機器:M&Aディール及び事業提携情報
    Summary SenGenix Inc (SenGenix) is a medical device company that discovers and develops point-of-care diagnostic tests based on fluorescently responsive sensors for delivering patient data to clinicians. The company develops specific molecular sensors for each analyte in its POCT product portfolio. …
  • ARCA biopharma Inc (ABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Clover Corp Ltd (CLV):企業の財務・戦略的SWOT分析
    Summary Clover Corp Ltd (Clover), a subsidiary of Washington H. Soul Pattinson and Company Ltd, is a developer of science-based bioactives. The company offers products such as DHA oils, DHA powders and microencapsulation. It delivers bioactive ingredients through encapsulation. Clover’s refined tuna …
  • Mentor Graphics Corporation (MENT):企業の財務・戦略的SWOT分析
    Mentor Graphics Corporation (MENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sekisui Diagnostics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sekisui Diagnostics LLC (Sekisui Diagnostics), a subsidiary of Sekisui Chemical Co Ltd, is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company provides products such as coagulation, clinical chemistry, virotech products, OS …
  • Visiomed Group SA (ALVMG):医療機器:M&Aディール及び事業提携情報
    Summary Visiomed Group SA (Visiomed) is a medical device company. The company develops and distributes electronic medical devices. It offers screening and diagnosis products, pain relief products, prevention and treatment products, hearing and optics, family hygiene, children’s optics, baby bottle t …
  • NeoGenomics Inc (NEO):企業の財務・戦略的SWOT分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆